113 related articles for article (PubMed ID: 15713685)
1. Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia.
DiCostanzo CA; Moore MC; Lautz M; Scott M; Farmer B; Everett CA; Still JG; Higgins A; Cherrington AD
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E46-52. PubMed ID: 15713685
[TBL] [Abstract][Full Text] [Related]
2. Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.
Kipnes M; Dandona P; Tripathy D; Still JG; Kosutic G
Diabetes Care; 2003 Feb; 26(2):421-6. PubMed ID: 12547873
[TBL] [Abstract][Full Text] [Related]
3. Inclusion of low amounts of fructose with an intraportal glucose load increases net hepatic glucose uptake in the presence of relative insulin deficiency in dog.
Shiota M; Galassetti P; Igawa K; Neal DW; Cherrington AD
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1160-7. PubMed ID: 15671083
[TBL] [Abstract][Full Text] [Related]
4. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768
[TBL] [Abstract][Full Text] [Related]
5. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
[TBL] [Abstract][Full Text] [Related]
6. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
[TBL] [Abstract][Full Text] [Related]
7. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
An Z; DiCostanzo CA; Moore MC; Edgerton DS; Dardevet DP; Neal DW; Cherrington AD
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E300-6. PubMed ID: 18029444
[TBL] [Abstract][Full Text] [Related]
8. Dose-response effect of a single administration of oral hexyl-insulin monoconjugate 2 in healthy nondiabetic subjects.
Wajcberg E; Miyazaki Y; Triplitt C; Cersosimo E; DeFronzo RA
Diabetes Care; 2004 Dec; 27(12):2868-73. PubMed ID: 15562199
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery.
Moore MC; Burish MJ; Farmer B; Neal DW; Pan C; Cherrington AD
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E845-53. PubMed ID: 12773306
[TBL] [Abstract][Full Text] [Related]
11. Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial.
Clement S; Dandona P; Still JG; Kosutic G
Metabolism; 2004 Jan; 53(1):54-8. PubMed ID: 14681842
[TBL] [Abstract][Full Text] [Related]
12. Impact of infection on glucose-dependent liver glucose uptake during TPN: interaction with insulin.
Chen SS; Donmoyer CM; Pearson DA; Poole A; Zhang Y; Lacy DB; McGuinness OP
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E286-95. PubMed ID: 14532169
[TBL] [Abstract][Full Text] [Related]
13. Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
Moore MC; Dicostanzo CA; Smith MS; Farmer B; Rodewald TD; Neal DW; Williams PE; Cherrington AD
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E768-77. PubMed ID: 18212022
[TBL] [Abstract][Full Text] [Related]
14. Unlike mice, dogs exhibit effective glucoregulation during low-dose portal and peripheral glucose infusion.
Moore MC; Cardin S; Edgerton DS; Farmer B; Neal DW; Lautz M; Cherrington AD
Am J Physiol Endocrinol Metab; 2004 Feb; 286(2):E226-33. PubMed ID: 14519598
[TBL] [Abstract][Full Text] [Related]
15. The effect of vagal cooling on canine hepatic glucose metabolism in the presence of hyperglycemia of peripheral origin.
DiCostanzo CA; Dardevet DP; Williams PE; Moore MC; Hastings JR; Neal DW; Cherrington AD
Metabolism; 2007 Jun; 56(6):814-24. PubMed ID: 17512315
[TBL] [Abstract][Full Text] [Related]
16. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.
Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E380-4. PubMed ID: 18056788
[TBL] [Abstract][Full Text] [Related]
17. Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.
Moore MC; Kimura K; Shibata H; Honjoh T; Saito M; Everett CA; Smith MS; Cherrington AD
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E225-31. PubMed ID: 15755767
[TBL] [Abstract][Full Text] [Related]
18. A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog.
Rivera N; Everett-Grueter CA; Edgerton DS; Rodewald T; Neal DW; Nishimura E; Larsen MO; Jacobsen LO; Kristensen K; Brand CL; Cherrington AD
J Pharmacol Exp Ther; 2007 May; 321(2):743-52. PubMed ID: 17308040
[TBL] [Abstract][Full Text] [Related]
19. Inhalation of human insulin (exubera) augments the efficiency of muscle glucose uptake in vivo.
Edgerton DS; Cherrington AD; Williams P; Neal DW; Scott M; Bowen L; Wilson W; Hobbs CH; Leach C; Kuo MC; Strack TR
Diabetes; 2006 Dec; 55(12):3604-10. PubMed ID: 17130510
[TBL] [Abstract][Full Text] [Related]
20. Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.
Clement S; Still JG; Kosutic G; McAllister RG
Diabetes Technol Ther; 2002; 4(4):459-66. PubMed ID: 12396740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
